High-dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open-label clinical trial using an objective score of clinical evaluation system-Reference-Cited by-同舟云学术

High-dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open-label clinical trial using an objective score of clinical evaluation system

Published:2017-04-12 Issue:7 Volume:31 Page:1157-1160
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Guarneri A.¹,Cioni M.¹,Rongioletti F.²

Affiliation:

1. Section of Dermatology; DISSAL; University of Genoa and S. Martino University Hospital; Genoa Italy

2. Unit of Dermatology; Department of Medical Sciences and Public Health; University of Cagliari; Cagliari Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14244/fullpdf

Reference20 articles.

1. Scleromyxedema: a multicenter study characteristics, comorbidities, course, and therapy in 30 patients;Rongioletti;J Am Acad Dermatol,2013

2. Mucinoses

3. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG);Blum;Medicine (Baltimore),2008

4. Course of modified rodnan skin score in systemic sclerosis clinical trials: analysis of 3 large multicenter, randomized clinical trials;Amjadi;Arthritis Rheum,2009

5. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema;Rongioletti;J Am Acad Dermatol,2001

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma cell‐directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema;Journal of the European Academy of Dermatology and Venereology;2024-07-31

2. Lenalidomide and Dexamethasone in Scleromyxedema: A Case Report of Long-Term Efficacy and Challenges in a 54-Year-Old Patient;Cureus;2024-06-26

3. Cutaneous Mucinoses;Rook's Textbook of Dermatology;2024-03-19

4. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema;Journal of the European Academy of Dermatology and Venereology;2024-03-08

5. Rare scleromyxedema granuloma-annulare-like pattern successfully treated with intravenous immunoglobulins;Italian Journal of Dermatology and Venereology;2024-02